195 related articles for article (PubMed ID: 30447393)
21. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
Fujii H; Cuvelier G; She K; Aslanian S; Shimizu H; Kariminia A; Krailo M; Chen Z; McMaster R; Bergman A; Goldman F; Grupp SA; Wall DA; Gilman AL; Schultz KR
Blood; 2008 Mar; 111(6):3276-85. PubMed ID: 17925486
[TBL] [Abstract][Full Text] [Related]
22. B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy.
de la Torre I; Moura RA; Leandro MJ; Edwards J; Cambridge G
Ann Rheum Dis; 2010 Dec; 69(12):2181-8. PubMed ID: 20581016
[TBL] [Abstract][Full Text] [Related]
23. B cells in chronic graft-versus-host disease.
McManigle W; Youssef A; Sarantopoulos S
Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
[TBL] [Abstract][Full Text] [Related]
24. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.
Pahl MV; Gollapudi S; Sepassi L; Gollapudi P; Elahimehr R; Vaziri ND
Nephrol Dial Transplant; 2010 Jan; 25(1):205-12. PubMed ID: 19684120
[TBL] [Abstract][Full Text] [Related]
25. Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD.
Rozmus J; Ivison S; Kariminia A; Leung VM; Sung S; Subrt P; Lee SJ; Boilard E; Walker I; Foley R; Lipton J; Gallagher G; Couban S; Schultz KR
Bone Marrow Transplant; 2018 Oct; 53(10):1263-1269. PubMed ID: 29563589
[TBL] [Abstract][Full Text] [Related]
26. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
Front Immunol; 2020; 11():1505. PubMed ID: 32849514
[TBL] [Abstract][Full Text] [Related]
27. B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.
Saliba RM; Sarantopoulos S; Kitko CL; Pawarode A; Goldstein SC; Magenau J; Alousi AM; Churay T; Justman H; Paczesny S; Reddy P; Couriel DR
Bone Marrow Transplant; 2017 Jul; 52(7):1010-1015. PubMed ID: 28481353
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
Debnath I; Roundy KM; Weis JJ; Weis JH
Mol Immunol; 2007 Mar; 44(9):2388-99. PubMed ID: 17140663
[TBL] [Abstract][Full Text] [Related]
29. Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.
Hillhouse EE; Thiant S; Moutuou MM; Lombard-Vadnais F; Parat R; Delisle JS; Ahmad I; Roy DC; Guimond M; Roy J; Lesage S
Biol Blood Marrow Transplant; 2019 Jan; 25(1):19-25. PubMed ID: 30244108
[TBL] [Abstract][Full Text] [Related]
30. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function.
Gorelik L; Cutler AH; Thill G; Miklasz SD; Shea DE; Ambrose C; Bixler SA; Su L; Scott ML; Kalled SL
J Immunol; 2004 Jan; 172(2):762-6. PubMed ID: 14707045
[TBL] [Abstract][Full Text] [Related]
31. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
32. Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study.
Naeije L; Kariminia A; Abdossamadi S; Azadpour S; Subrt P; Kuzeljevic B; Irvine MA; Walker I; Schultz KR
Biol Blood Marrow Transplant; 2020 Mar; 26(3):438-444. PubMed ID: 31756535
[TBL] [Abstract][Full Text] [Related]
33. CD21(-/low) B cells in human blood are memory cells.
Thorarinsdottir K; Camponeschi A; Cavallini N; Grimsholm O; Jacobsson L; Gjertsson I; Mårtensson IL
Clin Exp Immunol; 2016 Aug; 185(2):252-62. PubMed ID: 27010233
[TBL] [Abstract][Full Text] [Related]
34. B Cell Activating Factor (BAFF) in Long-term Kidney Transplant Recipients Is Not a Prognostic Marker for Allograft Dysfunction or Survival.
Kościelska-Kasprzak K; Bartoszek D; Myszka M; Kamińska D; Boratyńska M; Krajewska M; Klinger M
Transplant Proc; 2018; 50(6):1750-1754. PubMed ID: 30056894
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Kariminia A; Holtan SG; Ivison S; Rozmus J; Hebert MJ; Martin PJ; Lee SJ; Wolff D; Subrt P; Abdossamadi S; Sung S; Storek J; Levings M; Aljurf M; Arora M; Cutler C; Gallagher G; Kuruvilla J; Lipton J; Nevill TJ; Newell LF; Panzarella T; Pidala J; Popradi G; Szwajcer D; Tay J; Toze CL; Walker I; Couban S; Storer BE; Schultz KR
Blood; 2016 Jun; 127(24):3082-91. PubMed ID: 27020088
[TBL] [Abstract][Full Text] [Related]
36. Profiles of B-cell subsets in immunologically stable renal allograft recipients and end-stage renal disease patients.
Zhuang Q; Li H; Yu M; Peng B; Liu S; Luo M; Stefano GB; Kream RM; Ming Y
Transpl Immunol; 2020 Feb; 58():101249. PubMed ID: 31626945
[TBL] [Abstract][Full Text] [Related]
37. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
Sarantopoulos S; Stevenson KE; Kim HT; Bhuiya NS; Cutler CS; Soiffer RJ; Antin JH; Ritz J
Clin Cancer Res; 2007 Oct; 13(20):6107-14. PubMed ID: 17947475
[TBL] [Abstract][Full Text] [Related]
38. Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival.
Mayne CG; Amanna IJ; Hayes CE
Mol Immunol; 2009 Dec; 47(2-3):590-9. PubMed ID: 19815275
[TBL] [Abstract][Full Text] [Related]
39. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.
Sasaki Y; Casola S; Kutok JL; Rajewsky K; Schmidt-Supprian M
J Immunol; 2004 Aug; 173(4):2245-52. PubMed ID: 15294936
[TBL] [Abstract][Full Text] [Related]
40. Alteration of B cell subsets and the receptor for B cell activating factor (BAFF) in paediatric patients with type 1 diabetes.
Parackova Z; Klocperk A; Rataj M; Kayserova J; Zentsova I; Sumnik Z; Kolouskova S; Sklenarova J; Pruhova S; Obermannova B; Petruzelkova L; Lebl J; Kalina T; Sediva A
Immunol Lett; 2017 Sep; 189():94-100. PubMed ID: 28414179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
